| Development and validation of a penicillin allergy clinical decision rule JA Trubiano, S Vogrin, KYL Chua, J Bourke, J Yun, A Douglas, CA Stone, ... JAMA internal medicine 180 (5), 745-752, 2020 | 167 | 2020 |
| The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study KYL Chua, S Vogrin, S Bury, A Douglas, NE Holmes, N Tan, NK Brusco, ... Clinical infectious diseases 73 (3), 487-496, 2021 | 102 | 2021 |
| Emerging infections caused by non-Aspergillus filamentous fungi AP Douglas, SCA Chen, MA Slavin Clinical Microbiology and Infection 22 (8), 670-680, 2016 | 95 | 2016 |
| Ibrutinib may impair serological responses to influenza vaccination AP Douglas, JA Trubiano, I Barr, V Leung, MA Slavin, CS Tam Haematologica 102 (10), e397, 2017 | 93 | 2017 |
| Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool M Devchand, KF Urbancic, S Khumra, AP Douglas, O Smibert, E Cohen, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (3), 1063-1065. e5, 2019 | 81 | 2019 |
| The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study JA Trubiano, O Smibert, A Douglas, M Devchand, B Lambros, NE Holmes, ... Open forum infectious diseases 5 (12), ofy306, 2018 | 73 | 2018 |
| Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021 AP Douglas, OC Smibert, A Bajel, CL Halliday, O Lavee, B McMullan, ... Internal Medicine Journal 51, 143-176, 2021 | 68 | 2021 |
| FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging AP Douglas, KA Thursky, LJ Worth, E Drummond, A Hogg, RJ Hicks, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 166-173, 2019 | 55 | 2019 |
| The role of in vivo and ex vivo diagnostic tools in severe delayed immune-mediated adverse antibiotic drug reactions A Copaescu, E Mouhtouris, S Vogrin, F James, KYL Chua, NE Holmes, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (5), 2010-2015. e4, 2021 | 33 | 2021 |
| Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized clinical trial AM Copaescu, S Vogrin, F James, KYL Chua, MT Rose, J De Luca, ... JAMA internal medicine 183 (9), 944-952, 2023 | 32 | 2023 |
| The safety of antibiotic skin testing in severe T-cell–mediated hypersensitivity of immunocompetent and immunocompromised hosts JA Trubiano, AP Douglas, M Goh, MA Slavin, EJ Phillips The Journal of Allergy and Clinical Immunology: In Practice 7 (4), 1341-1343. e1, 2019 | 30 | 2019 |
| Safety of cephalosporins in penicillin class severe delayed hypersensitivity reactions JA Trubiano, KYL Chua, NE Holmes, A Douglas, E Mouthoris, M Goh, ... The journal of allergy and clinical immunology. In practice 8 (3), 1142, 2020 | 28 | 2020 |
| Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey A Khanina, KF Urbancic, GM Haeusler, DCM Kong, AP Douglas, SY Tio, ... Journal of Antimicrobial Chemotherapy 76 (1), 253-262, 2021 | 26 | 2021 |
| PCR-based tests for the early diagnosis of sepsis. Where do we stand? AN Ginn, CL Halliday, AP Douglas, SCA Chen Current opinion in infectious diseases 30 (6), 565-572, 2017 | 20 | 2017 |
| Herpes zoster meningoencephalitis: not only a disease of the immunocompromised? A Douglas, P Harris, F Francis, R Norton Infection 38 (1), 73-75, 2010 | 20 | 2010 |
| Quality of inpatient antimicrobial use in hematology and oncology patients AP Douglas, L Hall, RS James, LJ Worth, MA Slavin, KA Thursky Infection Control & Hospital Epidemiology 42 (10), 1235-1244, 2021 | 18 | 2021 |
| Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting O Xie, MA Slavin, BW Teh, A Bajel, AP Douglas, LJ Worth BMC Infectious Diseases 20, 1-7, 2020 | 18 | 2020 |
| [18F] FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial A Douglas, K Thursky, T Spelman, J Szer, A Bajel, S Harrison, SY Tio, ... The Lancet Haematology 9 (8), e573-e584, 2022 | 16 | 2022 |
| Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility AP Douglas, C Marshall, SL Baines, D Ritchie, J Szer, V Madigan, ... Journal of Medical Microbiology 68 (3), 303-308, 2019 | 16 | 2019 |
| What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer A Douglas, E Lau, K Thursky, M Slavin Current opinion in infectious diseases 30 (6), 552-564, 2017 | 16 | 2017 |
